引 致 更 改 給 病 人 的 產 品 資 訊 的 藥 物 不 良 反 應 警 示
|
| |
| Singapore: HSA suspends Zerin® (Paracetamol) Tablets 500mg (English Only) |
| |
The Health Sciences Authority (HSA) is alerting members of the public to the suspension of the licence of Zerin® tablets 500mg. Zerin® tablets contain paracetamol, are manufactured by Jayson Pharmaceuticals Ltd and distributed in Singapore by Ziwell Medical (S) Pte Ltd. From HSA's ongoing post marketing surveillance, four reports of product defects were investigated since August 2011 regarding Zerin® tablets, where some tablets from different batches were found to contain small foreign particles. Result has shown that the foreign particles are inert, non-toxic substances and assessed to pose minimal risk to consumers. Tests also showed that the paracetamol content in Zerin® tablets complies with registered specifications. Consumers who have stocks of Zerin® tablets are advised to stop consuming the product. Consumers who have already taken the affected product should not be unduly alarmed as the product defect has been assessed to pose minimal risk to health.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/publish/hsaportal/en/news_events/press_releases/Latest/hsa_suspends_zerin.html
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/ Tuesday, September 20, 2011
Issued at HKT 12:30
|
| |
